Serveur d'exploration sur l'Indium - Curation (Accueil)

Index « MedMesh.i » - entrée « Survival Rate »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Survival Analysis < Survival Rate < Sus scrofa  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]
Ident.Authors (with country if any)Title
000935 (2013) InP/ZnS as a safer alternative to CdSe/ZnS core/shell quantum dots: in vitro and in vivo toxicity assessment.
001102 (2012) Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients.
001473 (2011) Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by ¹¹¹Indium-octreotide imaging.
001624 (2011) Adjuvant radioimmunotherapy improves survival of rats after resection of colorectal liver metastases.
001953 (2010) Gene expression of somatostatin receptor 4 predicts clinical outcome of patients with metastatic neuroendocrine tumors treated with somatostatin analogs.
001C02 (2009) Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging.
002111 (2009) First report on a prospective trial with yttrium-90-labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma.
002534 (2008) Use of local (111)in-capromab pendetide scan results to predict outcome after salvage radiotherapy for prostate cancer.
002627 (2007) Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma.
002672 (2007) Detection of abdominal aortic graft infection: comparison of magnetic resonance imaging and indium-labeled white blood cell scanning.
002A74 (????) Pegylated Liposomal Doxorubicin HCL (Caelyx) in combination with Sandostatin LAR as salvage therapy in patients with small-cell lung cancer.
002D56 (2006) Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer.
002D75 (2005) Large-volume liver metastases from neuroendocrine tumors: hepatic intraarterial 90Y-DOTA-lanreotide as effective palliative therapy.
002E98 (????) The therapeutic value of SST-A octreotide alone or with adjuvant treatment in patients with advanced medullary thyroid carcinoma and positive (111)In-octreotide scan.
002F92 (2005) Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons.
003046 (2004) Targeting of HER2 antigen for the treatment of disseminated peritoneal disease.
003219 (2004) [Diagnosis and treatment for gastrinoma].
003244 (2004) Tumour-derived and host-derived nitric oxide differentially regulate breast carcinoma metastasis to the lungs.
003563 (2003) Expression of somatostatin receptors in uveal melanomas.
003749 (2002) Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
003763 (2002) Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Survival Rate" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Survival Rate" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Survival Rate
}}

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024